BeiGene Ltd ADR buy Royal Bank of Canada
Start price
12.09.23
/
50%
€191.00
Target price
12.09.24
€241.54
Performance (%)
-6.28%
End price
13.09.24
€179.00
Summary
This prediction ended on 13.09.24 with a price of €179.00. With a performance of -6.28%, the BUY prediction for BeiGene Ltd ADR by Royal_Bank_of_Canada closed slightly in the red. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BeiGene Ltd ADR | -2.222% | -2.222% | 29.412% |
| iShares Core DAX® | 2.554% | 0.562% | 14.142% |
| iShares Nasdaq 100 | 2.742% | -0.599% | 30.370% |
| iShares Nikkei 225® | 6.584% | 4.336% | 49.372% |
| iShares S&P 500 | 1.930% | -0.507% | 24.257% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread BeiGene Ltd ADR diskutieren
BeiGene, Ltd. (NASDAQ: BGNE) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $259.00 price target on the stock.
Ratings data for BGNE provided by MarketBeat
In the thread Trading BeiGene Ltd ADR
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten